Geode Capital Management’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Sell |
980,929
-1,073,000
| -52% | -$1.35M | ﹤0.01% | 3267 |
|
|
2025
Q1 | $1.88M | Buy |
2,053,929
+81,534
| +4% | +$74.5K | ﹤0.01% | 3060 |
|
|
2024
Q4 | $3.14M | Sell |
1,972,395
-58,048
| -3% | -$92.3K | ﹤0.01% | 2966 |
|
|
2024
Q3 | $3.98M | Buy |
2,030,443
+124,782
| +7% | +$245K | ﹤0.01% | 2884 |
|
|
2024
Q2 | $3.13M | Buy |
1,905,661
+63,478
| +3% | +$104K | ﹤0.01% | 2965 |
|
|
2024
Q1 | $9.47M | Buy |
1,842,183
+47,535
| +3% | +$244K | ﹤0.01% | 2359 |
|
|
2023
Q4 | $10.3M | Buy |
1,794,648
+217,507
| +14% | +$1.25M | ﹤0.01% | 2329 |
|
|
2023
Q3 | $7.54M | Buy |
1,577,141
+465,590
| +42% | +$2.23M | ﹤0.01% | 2422 |
|
|
2023
Q2 | $4.72M | Buy |
1,111,551
+41,927
| +4% | +$178K | ﹤0.01% | 2715 |
|
|
2023
Q1 | $5.68M | Buy |
1,069,624
+38,637
| +4% | +$205K | ﹤0.01% | 2579 |
|
|
2022
Q4 | $6.47M | Buy |
1,030,987
+45,617
| +5% | +$286K | ﹤0.01% | 2513 |
|
|
2022
Q3 | $10.4M | Buy |
985,370
+310,597
| +46% | +$3.28M | ﹤0.01% | 2221 |
|
|
2022
Q2 | $3.66M | Buy |
674,773
+26,016
| +4% | +$141K | ﹤0.01% | 2866 |
|
|
2022
Q1 | $5.96M | Buy |
648,757
+287,125
| +79% | +$2.64M | ﹤0.01% | 2701 |
|
|
2021
Q4 | $5.46M | Buy |
361,632
+19,417
| +6% | +$293K | ﹤0.01% | 2851 |
|
|
2021
Q3 | $8.17M | Buy |
+342,215
| New | +$8.17M | ﹤0.01% | 2611 |
|